Correlation Between AptaBio Therapeutics and Seoul Semiconductor

Can any of the company-specific risk be diversified away by investing in both AptaBio Therapeutics and Seoul Semiconductor at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AptaBio Therapeutics and Seoul Semiconductor into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between AptaBio Therapeutics and Seoul Semiconductor Co, you can compare the effects of market volatilities on AptaBio Therapeutics and Seoul Semiconductor and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AptaBio Therapeutics with a short position of Seoul Semiconductor. Check out your portfolio center. Please also check ongoing floating volatility patterns of AptaBio Therapeutics and Seoul Semiconductor.

Diversification Opportunities for AptaBio Therapeutics and Seoul Semiconductor

0.91

Correlation Coefficient

AptaBio Therapeutics  Seoul Semiconductor

Almost no diversification

The 3 months correlation between AptaBio and Seoul is 0.91. Overlapping area represents the amount of risk that can be diversified away by holding AptaBio Therapeutics and Seoul Semiconductor Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seoul Semiconductor and AptaBio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AptaBio Therapeutics are associated (or correlated) with Seoul Semiconductor. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seoul Semiconductor has no effect on the direction of AptaBio Therapeutics i.e., AptaBio Therapeutics and Seoul Semiconductor go up and down completely randomly.

Pair Corralation between AptaBio Therapeutics and Seoul Semiconductor

Assuming the 90 days trading horizon AptaBio Therapeutics is expected to generate 1.1 times more return on investment than Seoul Semiconductor. However, AptaBio Therapeutics is 1.1 times more volatile than Seoul Semiconductor Co. It trades about -0.06 of its potential returns per unit of risk. Seoul Semiconductor Co is currently generating about -0.08 per unit of risk. If you would invest  794,000  in AptaBio Therapeutics on October 6, 2024 and sell it today you would lose (129,000) from holding AptaBio Therapeutics or give up 16.25% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	100.0%
Values	Daily Returns

AptaBio Therapeutics  vs.  Seoul Semiconductor Co

AptaBio Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AptaBio Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Seoul Semiconductor

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Seoul Semiconductor Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with AptaBio Therapeutics and Seoul Semiconductor

The main advantage of trading using opposite AptaBio Therapeutics and Seoul Semiconductor positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AptaBio Therapeutics position performs unexpectedly, Seoul Semiconductor can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seoul Semiconductor will offset losses from the drop in Seoul Semiconductor's long position.

The idea behind AptaBio Therapeutics and Seoul Semiconductor Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.